Company / Operating Cash Flow
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Operating Cash Flow History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$1.6M
FY2015
5-year range
-$1.6M / -$936.4K
FY2011-FY2015
Trend
-35.6%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$1M to -$2M over the past 3 years.
Based on SEC 10-K filings.
-$2M in FY2015.
Declined from -$1M to -$2M over the past 3 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2015, operating cash flow decreased 35.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | -$1.6M | -35.6% |
| FY2013 | -$1.2M | +11.3% |
| FY2012 | -$1.4M | -45.2% |
| FY2011 | -$936.4K | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026